Conference Call and Webcast to Follow
THE WOODLANDS, Texas, April 21 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2009 financial results on Tuesday, April 28, 2009 before the financial markets open. Lexicon management will hold a conference call to discuss its clinical development progress and financial results for first quarter 2009 at 11:00 a.m. Eastern Time on April 28, 2009.
The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international). The conference ID for all callers is 95206081. Investors can access a live webcast of the call at www.lexpharma.com. An archived version of the webcast will be available on the website through May 5, 2009.
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.
Safe Harbor Statement
This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic
|SOURCE Lexicon Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved